← All research updates

Can a blood test help track glioblastoma?

Original title: Circulating miRNAs for glioblastoma monitoring: from biofluid to clinical decision.

How far along is this research?

This looks across many earlier studies rather than running a new one.

This is a review of past studies, and these tests are not ready for regular care.

The short version

Researchers are testing whether tiny markers in blood or spinal fluid can show how a brain tumor is doing.

What was studied. Researchers reviewed clinical studies of circulating miRNAs in people with glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary, including glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. miRNAs are tiny bits of genetic material that float in blood, serum, and the fluid around the brain and spine.

What they found. Some miRNAs were higher than normal in people with glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary. Others were lower than normal. Panels that measured several miRNAs at once worked better than any single marker. Levels of some miRNAs shifted with treatment, and a few helped tell real tumor growth apart from swelling caused by treatment.

What this means, and what it doesn't

What it could mean: MRI scans cannot always tell tumor growth from treatment effects. A simple blood or fluid test might help with that someday. It would be much easier on a patient than more surgery.

What it doesn't mean: This is not a test you can get today. It is a summary of past studies, not a new result. These markers are not approved, not standard care, and not proven to work. Results still vary a lot between labs and between people. This is not a treatment, and it is not a cure.

Source: PubMed, July 28, 2026 · Read the original

This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.

Report a problem with this summary